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ABSTRACT 
This study was designed to examine the effect of the methanolic extract of the root of Cissampelos mucronata on embryo-foetal 
development in rats. A total of 60 nulliparous female rats weighing 143-215gm approximately 13 weeks of age in the proestrous 
stage were cohabited (1:1)  with 60 male rats to obtain 40 pregnant rats which were assigned to four dosage groups (10 rats per 
group, I-IV) by random stratification to nearly equalized body weight difference between groups on gestataion day zero GD 0. Group 
I served as the control group while rats in Groups II, III and IV were administered with 100mgkg-1, 200mgkg-1and 300mgkg-1 doses 
of the extract respectively from implantation (GD6) to the day prior to the expected day of parturition (GD20). On GD20, the female 
rats were euthanized and uterine implantation data including live and dead foetuses were counted, weighed, gender determined and 
observed for external malformations. The results indicate that administration of the extract from gestation day 6 to 20 had no 
significant effect on the number of implantation sites while resorptions sites were significantly (p<0.05-0.001) high in a dose 
dependent manner. There was a decrease in the foetal weight, placental weight and crown rump length of the rats indicating that 
administration of the extract from gestation day 6 to 20 caused resorptions in pregnancy and decrease in foetal weight, placental 
weight and crown rump length rats in a dose dependent manner. 
 




Cissampelos mucronata (A. Rich) belongs to the family 
Menispermaceae and is highly specialized in its extraordinarily 
rich diversification of benzyltetrahydroisoquinoline and 
aporphine derivatives (Watson and Dallwitz, 1992). Because of 
its richness in alkaloids, this family is used worldwide in 
traditional medicine to treat a variety of ailments. It is used to 
facilitate childbirth, as an abortifacient, as an emmenagogue, 
to treat stomach pains and as a diuretic (Burkill , 1997). Its 
fresh aerial parts are used to regulate menstruation (Elujoba, 
1995). Ash obtained from the leaves, twigs and root bark are 
eaten to treat side pain (Baerts and Lehmann, 1989) and the 
sap of the whole plant is mixed with Heliotropium indicum L. 
and drunk to treat Leukorrhea (Adjanohoun et al.1989). 
Decoction of the stem bark and leaves is also drunk to calm 
nerves (Nwosu, 1999). The root is used to treat abdominal 
pains, swollen stomach and gastro-intestinal upset due to 
bewitchment (Gelfand et al. 1985; Chhabra et al. 1990). It is 
also used to prevent or arrest uterine haemorrhage, painful 
uterus, to treat infertility, to prevent abortion (Gelfand et 
al.1985; Van Wyk and Gericke, 2000) and  to treat 










In Nigeria, like many African countries Cissampelos mucronata 
(A. Rich) is  usually prepared in the form of infusions, 
decoctions, tinctures or syrups in the treatment of various 
ailments. Its indigenous names in Nigeria include Jibdar Kasa 
or Damarji (Hausa) and abakenwo in Igbo (Burkill, 1997), 
Barwada (Kanuri), Magirahi (Fulfulde), Zagaduwa (Marghi) 
and Kwahara or Kwahirka (Babur/Bura) while its English name 
is Ivy vine. Despite its various uses during pregnancy a search 
conducted for embryofetal (developmental) effect of 
Cissampelos mucronata found no results. Against this 
background the study was designed to examine the effect of 
the methanolic extract of the root of Cissampelos mucronata 




MATERIALS AND METHODS 
 
Collection and Identification of Plant Materials 
The plant was collected around Giwa Military Barracks in 
Maiduguri metropolis latitude 11° 50' 42" North and longitude 
13° 9' 36" East. The plant was identified and authenticated as 
Cissampelos mucronata A. Rich by Professor S. S. Sanusi 
(botanist) of the Department of Biological Sciences, University of 
Maiduguri, Borno state, Nigeria. A specimen voucher (CM.01) of 
the plant was prepared and deposited at the herbarium of the 
Department of Veterinary Physiology and Pharmacology, 
University of Maiduguri, Borno state. The collection, identification 
and storage of the plant material was carried out according to 
the World Health Organization’s guidelines on quality control 
methods for medicinal plant materials (WHO, 1998) and quality 
specifications of plant materials and preparations (WHO, 1993). 
The root was then sun-dried, pulverised into powdered form 
using a pestle and mortar and then stored in cellophane bags at 
room temperature.  
 
Extraction Procedures  
The World Health Organization’s research guidelines for 
evaluating the safety and efficacy of herbal medicines (WHO, 
1993) was adopted for the extraction of the root of 
Cissampelos mucronata. A total of one hundred grams (100g) 
of the pulverised root was subjected to exhaustive soxhlet 
extraction in methanol (500ml) for 72 h at 60oC. The extract 
obtained was then concentrated in a water bath until a 
constant dark sticky residue was obtained, this gave a total 
mean extract weight yield of 11.34g w/w of extract which was 
further oven dried and maintained in a desiccator until a 
constant weight was obtained and the extract obtained was 
then stored in a stoppered container in refrigerator at - 4oC 
until required.  
 
The stock solution of the extract was prepared by dissolving a 
known weight (2g) of the extract in a known volume of 
distilled water (50ml) in the presence of 1 drop (0.05ml) of 
dimethylsulfoxide (DMSO) and allowed to stand for about 45-
60 minutes, the water soluble portion was separated off using 
a fine needle syringe and the dry weight of the marc 
determined after drying the wet marc on a hot plate. The 
actual concentration of the water soluble portion of the extract 
was thus determined and required concentrations were then 
prepared from the stock solution by serial dilutions. 
 
Embryofetal  study 
A total of 60 nulliparous female rats weighing 143-215gm and 
approximately 13 weeks of age and 60 male rats weighing 165-
220 gm  that have not being subjected to any experimental 






procedure were used in this study and  cared for according to 
the Guiding Principles for the Care and Use of Animals based on 
the Helsinki Declaration as amended by World Medical Assembly, 
Venice, Italy (Declaration of Helsinki, 1996). The study was 
conducted according to methods outlined by U.S, EPA, 1998; 
U.S.FDA, 2000 and ICH, 2005. Female rats that were in the 
proestrous stage of the oestrous cycle were cohabited (1:1) with 
the males and were considered pregnant based on the presence 
of sperm cells or a vaginal plug. The experiment was started 
with 60 female rats in order to achieve the minimum and 
sufficient number of 10 pregnant rats per group (experimental 
and control) thus, the 40 pregnant rats obtained were assigned 
to four dosage groups (10 rats per group, I-IV) by random 
stratification to nearly equalized body weight difference between 
groups on GD 0.  
 
Group I served as the control group and were administered 
normal saline equivalent to the volume administered to the 
highest dosed experimental rats while rats in Groups II, III 
and IV were administered with 100mgkg-1, 200mgkg-1and 
300mgkg-1 doses of the extract respectively (Dosages were 
calculted based on an initial acute toxicity study that gave an 
LD50 of above 2000mg/kg/oral.). The rats were administered 
the extract daily by gavage from implantation (GD6) to the 
day prior to the expected day of parturition (GD20) and 
observed daily for mortality and toxicological effects. On 
GD20, the female rats were euthanized, a caesarean section 
performed and macroscopic post-mortem examination 
performed on the uterus and ovaries.  
 
Uterine implantation data including live and dead foetuses were 
obtained from the uterus, counted, weighed, gender determined 
and observed for external malformations. Uteri without grossly 
visible implantation sites were stained by aluminium sulphide 
according to the procedure of Salewski, (1964) to identify the 
presence of early resorption sites while rats with no stained 
implantation sites were considered not pregnant. 
 
Statistical Analysis 
Data obtained from this study were expressed as the mean 
value  standard error of mean. The data were analysed using 
one way analysis of variance (ANOVA) and differences 
between means of control and treated groups were 
determined using Statistical Package for Social Scientist (SPSS 






Effect of the extract on maternal body weights (GD 6-21). 
The effect of the methanolic extract of the root of Cissampelos 
mucronata on mean maternal body weights administered from 
Gestation day 6 to Gestation day 20 are presented in Tables 1. 
The administration of the extract from gestation day 6 was 
observed to have caused a significant (p<0.05-0.01) decrease in 
body weight gain in the rats that were administered with 100 
and 200 mgkg-1 of the extract when compared with the control 
(0 mgkg-1) group that had a significant(p<0.05-0.001)  body 
weight increase however the effect was more severe in the 
group administered with 300 mgkg-1 of the extract which 
presented with a significant body weight loss due to the fact that 
their pregnancy status did not advance beyond gestation  day 6 
(Table 2).  
 






Effect of the extract during GD 6-20 on caesarean section 
and foetal parameters 
The effect of the administration of the extract on caesarean 
section and foetal parameters are presented on Table 2 and 3. 
The results indicate that administration of the extract from 
gestation day 6 to 20 had no significant effect on the number 
of implantation sites counted.  Resorptions sites were however 
significantly (p<0.05-0.001) high following the administration 
of 100, 200 and 300 mgkg-1 of the extract with the 300 mgkg-1 
dosed group showing a 100% resorptions due to the failure of 
the pregnancies in this group to progress beyond gestation 
day 6. Dead foetuses were completely absent in the 300 
mgkg-1 dosed group and significantly (p<0.05-0.01) high in 
the 100 and 200 mgkg-1 dosed groups when compared with 
the control group while viable foetuses were completely 
absent in the 300 mgkg-1 dosed group and significantly 
(p<0.05-0.01) low in the 100 and 200 mgkg-1 dosed group. 
The number of males and females counted among the viable 
and dead foetuses were not significantly different from each 
other. 
There was a decrease in the foetal weight, placental weight 
and crown rump length of the rats dosed with 100 and 200 
mgkg-1 of the extract with significance (p<0.05-0.01) observed 




Table 1:  Effect of the administration of the methanolic extract of the root of Cissampelos mucronata during GD 6-21 
on mean maternal body weights. 
  Maternal weights (g)  Body weight differences 
Doses (mgkg-1) N     GD 0    GD 6      GD 21 GD0-GD6        GD6-GD21 
0 10 149.48±9.57 161.90±9.26 203.50±8.17aa   12.42±2.58      41.61±2.14 
100 10 143.41±7.79 157.85±8.21 187.11±7.72a   14.44±2.66      29.25±2.74* 
200 10 153.19±9.13 166.95±8.64 190.26±8.18   13.76±2.85      23.31±3.04** 
300 09 162.86±9.92 180.48±11.49 172.40±9.43   17.62±6.13      -8.09±5.58** 
 Results are presented as Means ± SEM. Significance relative to body weight on corresponding gestation day   **p<0.01,*p<0.05,  
N=Number of rats per group and GD= Gestation Day.  
 
 
Table 2: Effect of the administration of the methanolic extract of the root of Cissampelos mucronata during GD 6-20 
on  caesarean section parameters . 
 Doses administered(mgkg-1) 
Parameter (g) 0 100 200 300 
Number of Females Mated 10 10 10 09 
      No. Pregnant (%)  10 (100) 10 (100) 10 (100) 9 (100) 
      No. Litters with Viable Foetuses 10 (100) 10 (100) 10 (100) 9 (100) 






No. of implantation sites 12.00 ± 0.33 12.50 ± 0.40 11.70 ± 0.45 11.44 ± 0.42 
Resorptions 0.00 ± 0.00 2.10 ± 0.28** 3.00 ± 0.39** 12.56 ±0.56** 
Mean No. of Dead Foetuses per female 0.00 ± 0.00 0.70 ± 0.30* 1.10 ± 0.23** ___a 
Total No. of Dead Foetuses per litter 00.00 07.00 11.00 ___a 
       Males per litter (n) 00 04 04 ___a 
       Females per litter (n) 00 03 07 ___a 
Significance relative to control (0 mgkg-1) **p<0.01,*p<0.05 
a Caesarean section parameters were not determined on non pregnant females. 
  Results are presented as Means ± SEM 
 
Table 3 : Effect of the administration of the methanolic extract of the root of Cissampelos mucronata during GD 6-20 
on foetal parameters . 
 Doses administered(mgkg-1) 
Parameter (g) 0 100 200 300 
Male : Female % ratio of Dead Foetuses  00 57:43 36:64 ___a 
Mean No. of Viable Foetuses per female 8.50 ±  0.45 6.50 ± 0.50** 5.20 ± 0.25** ___a 
Total No. of Viable Foetuses per litter 85.00 65.00 52.00 ___a 
       Males per litter (n) 46.00 35.00 24.00 ___a 
       Females per litter (n) 39.00 30.00 28.00 ___a 
Male : Female % ratio of Viable Foetuses  54:46 54:46 46:54 ___a 
Foetal weight(g) 3.55 ± 0.24 2.64 ± 0.12** 2.10 ± 0.22** ___a 
Placental weight(g) 0.72 ± 0.14 0.58 ± 0.02  0.54 ± 0.03 ___a 
Crown rump length(cm) 3.50 ± 0.08 2.87 ± 0.11** 2.20 ± 0.12** ___a 
  Significance relative to control (0 mgkg-1) **p<0.01,*p<0.05 
a Caesarean section parameters were not determined on non pregnant females. 




Administration of the extract of Cissampelos mucronata from 
gestation day 6 to gestation day 20 slowed down body weight 
increase in the treated rats. This suggests that exposure to 
the  aqueous extract of Cissampelos mucronata during 
pregnancy decreases pregnancy weight gain due to the loss of 
appetite observed during the course of the study as a result of 
the effect of the phytochemical constituents of the plant 
(Tsuda et al., 2005 and Yu et al., 2006 ).   
 






The dose dependent and significant increase in the number of 
resorption sites in rats treated with 100 and 200 mgkg-1 of the 
extract and 100% resorption in rats treated with 300 mgkg-1 of 
the extract as shown in Table 2 and the number of dead 
foetuses per female rat which  significantly increased with 
dose with the concominant low foetal weights and decreased 
crown rump length are all characteristic of the toxic effect of 
Cissampelos mucronata extract . The death of an embryo after 
implantation is defined as resorption - which is characterized 
as ‘in situ’ lyses of embryos or fetuses (Kalter, 1980). There 
was a significantly higher proportion of resorptions in 
Cissampelos mucronata extract treated mothers; hence it was 
possible to assume that Cissampelos mucronata extract was 
toxic to the embryos, causing its death after implantation. The 
toxic effect observed in this study might be attributed to the 
saponin contents of the extract because the negative effects 
of saponins on animal reproduction have been ascribed to 
their abortifacient, antizygotic and anti-implantation properties 
(Tewary et al., 1973; Stolzenberg and Parkhurst, 1976). 
Saponins from broom weed or commercial pharmaceutical 
grade saponins have been shown to cause abortion or death 
or both in rabbits, goats and cows when administered 
intravenously at concentrations above 2·3 mg/kg body weight 
(Dollahite et al.,1962) with the ones  isolated from the crude 
extract of Gleditischia horrida, Costus speciosus and 
Phytolacca dodecandra linked to sterility in mice (Chou et 
al.,1971;Tewary et al., 1973; Stolzenberg and Parkhurst, 
1976) while Quin and Xu (1998) found that the butanol extract 
of Mussaenda pubescens was capable of terminating 
pregnancy in rats. This toxic effect was confirmed by the lower 
body weight of fetuses and placentae in Cissampelos 
mucronata extract treated mothers. Normal fetal and organs 
growth and development are determined by a complex 
interplay between genetic, immunological, endocrinological, 
nutritional, vascular and environmental influences and a 
disturbance in one of these factors would disrupt normal 
growth and development (Chahoud et al.,1999).It is known 
that when a toxic agent causes death,or fetal growth delay 
without causing malformations, it can be related to the fact 
that it interferes with vital processes such as glycolysis, 
mitochondria function or membrane integrity.   
 
According to Holemans et al. 2003 and Ergaz et al. 2005 
reduction in fetal body weight could be related with nutrition, 
maternal metabolism and placental vascular alterations. 
Vascular placental pathology is a significant contributor for 
reduced growth in the intrauterine life (Ergaz et al., 2005). 
Placentae from Cissampelos mucronata extract treated animals 
were significantly smaller than those from control group, 
suggesting some alterations in these organs but as no 
histopathological analysis was performed, it was impossible to 
elucidate the cause of this weight reduction.  
 
In conclusion, our findings indicated that administration of the 
extract from gestation day 6 to 20 caused resorptions in 
pregnant and decrease in foetal weight, placental weight and 
crown rump length in rats, in a dose dependent manner. We 
recommend that further studies aimed at corroborating these 
findings be carried out.  
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